Azure Health Technology Limited commences first manufacturing run in the US for nutraceutical products
24 August 2020 Azure Health Technology Limited (AZT) today announced that it has commenced manufacturing the first batch of nutraceutical products for sale in the US, Australia and China. AZT’s wholly owned subsidiaries, Invictus BioPharma Ltd (based in…
New Deal Secures Potential COVID-19 Vaccine For Every Australian
20 August 2020 Release date: 19 August 2020 Australians will be among the first in the world to receive a COVID-19 vaccine, if it proves successful, through an agreement between the Australian Government and UK-based drug company AstraZeneca. Under…
Securing The Future Of Regenerative Medicine In Victoria
Date posted: 18 August 2020 Release date: 10 August 2020 The Victorian Government is growing the state’s world-leading medical research sector, securing the retention of the national headquarters of the Centre for Commercialisation of Regenerative Medicine (CCRM) Australia. CCRM speeds up…
AAMRI OIS Report 2020 – Highlights from 12 Victorian Independent Medical Research Institutes
17 August 2020 Release date: 14 August 2020 The AAMRI Operational Infrastructure Support (OIS) Program is essential to the 12 Victorian independent medical research institutes it supports. In 2018–2019 the Victorian Government provided $34.5M to these institutes to cover…
COVID-19 vaccine and treatment manufacture and supply chain RFI
11 August 2020 Close date: 20 August 2020 In response to the COVID-19 pandemic, the Australian Government is working to seek early access to and delivery of safe and effective COVID-19 vaccines and treatments as soon as they…
Novavax Announces Positive Phase 1 Data for its COVID-19 Vaccine Candidate
6 August 2020 Novavax, Inc., a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced Phase 1 data from its Phase 1/2 randomized, observer-blinded, placebo-controlled trial of its COVID‑19 vaccine with and without Matrix‑M™ adjuvant…
Premier’s statement on business restrictions – impacts for businesses
4 August 2020 Release date 3 August 2020 Yesterday Daniel Andrews, Premier of Victoria announced a series of business restrictions. These are in direct response to Victoria’s move to Stage 4 Restrictions in combating COVID-19 transmission. Read the…
AHHA position paper: the effective and sustainable adoption of virtual health care
4 August 2020 On 24 July 2020, The Australian Healthcare and Hospitals Association (AHHA) published a position paper as a supplement to Healthy people, Healthy systems: strategies for outcomes-focused and value-based healthcare entitled “The effective and sustainable adoption…
Medical research grant recipients announced, including COVID-19 research fund grants
4 August 2020 The Victorian Government is backing cutting-edge medical research projects to better understand, prevent and treat coronavirus. Seven projects will benefit from the government’s $5.5 million COVID-19 Research Fund, which will support continued jobs growth in a sector…
AustralaSian COVID-19 Trial (ASCOT) removes hydroxychloroquine and lopinavir/ritonavir arms of the trial
4 August 2020 Release date: 30 July 2020 Following reports that hydroxychloroquine and lopinavir/ritonavir are not effective in reducing mortality from COVID-19, the AustralaSian COVID-19 Trial (ASCOT) Steering Committee has also made the decision to remove the hydroxychloroquine and lopinavir/ritonavir…
AAMRI’s budget priority: secure the future of Australia’s next generation of talent
3 August 2020 Australian medical research institutes are raising the alarm about the precarious position facing our earlier-career scientists. In their 2020 Budget Submission the Association of Australian Medical Research Institutes (AAMRI) has outlined the risk of losing the next…
ARC Future Fellows pave the way for Australian research
4 August 2020 Release date 29 July 2020 The Australian Research Council (ARC) will support 100 mid-career researchers to grow knowledge and innovation for the benefit of the Australian community by undertaking high quality research. ARC Chief Executive…
